Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy.

Cardiovascular and interventional radiology·2022
Same author

Liver resection and ablation for squamous cell carcinoma liver metastases.

BJS open·2021
Same author

Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.

The British journal of surgery·2021
Same author

Postoperative chyle leak after pancreatic surgery - Is treatment effective?

Journal of visceral surgery·2021
Same author

Reinforced versus standard stapler transection on postoperative pancreatic fistula in distal pancreatectomy: multicentre randomized clinical trial.

The British journal of surgery·2021

Related Experiment Video

Updated: Mar 29, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Published on: August 14, 2017

15.6K

Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?

J G D'Haese1, J Neumann2, M Weniger1

  • 1Department of General, Visceral, Transplantation, Vascular and Thoracic Surgery, Hospital of the University of Munich, Munich, Germany.

Annals of Surgical Oncology
|December 10, 2015
PubMed
Summary

Associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) induces liver hypertrophy in hepatocellular carcinoma (HCC) patients. However, the high perioperative mortality rate makes ALPPS prohibitive for most HCC patients.

More Related Videos

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.8K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

1.4K

Related Experiment Videos

Last Updated: Mar 29, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Published on: August 14, 2017

15.6K
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.8K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

1.4K

Area of Science:

  • Hepatobiliary surgery
  • Surgical oncology
  • Liver transplantation

Background:

  • Extended liver resections for hepatocellular carcinoma (HCC) are challenging due to liver damage.
  • Associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) is a novel technique for inducing liver hypertrophy.
  • Limited data exists on ALPPS outcomes in HCC patients.

Purpose of the Study:

  • To investigate the outcomes of ALPPS in patients with HCC.
  • To compare ALPPS outcomes between HCC and colorectal liver metastases (CRLM) patients.
  • To identify factors influencing survival after ALPPS for HCC.

Main Methods:

  • Retrospective analysis of patients from the international ALPPS Registry (2010-2015).
  • Comparison of liver remnant hypertrophy, perioperative morbidity/mortality, and survival between HCC and CRLM groups.
  • Multivariate analysis to identify predictors of survival.

Main Results:

  • 35 HCC patients and 225 CRLM patients were analyzed.
  • HCC patients showed significant hypertrophy (47%), but lower than CRLM patients (76%).
  • 90-day mortality was significantly higher in HCC patients (31%) compared to CRLM patients (7%).
  • Older age (>61 years) was associated with reduced overall survival in HCC patients.

Conclusions:

  • ALPPS induces hypertrophy in HCC patients, enabling resection of intermediate-stage disease.
  • The high perioperative mortality (31%) makes ALPPS generally prohibitive for HCC.
  • ALPPS for HCC should be reserved for highly selected, younger patients with low-grade fibrosis.